135 related articles for article (PubMed ID: 28414972)
1. An LC-MS/MS method for quantification of AC0010, a novel mutant-selective epidermal growth factor receptor (EGFR) inhibitor, and its metabolites in human plasma and the application to a pharmacokinetic study.
Wang L; Zheng X; Wang W; Hu P; Jiang J
J Pharm Biomed Anal; 2017 Jul; 141():9-18. PubMed ID: 28414972
[TBL] [Abstract][Full Text] [Related]
2. Development of an UPLC-MS/MS method for quantification of Avitinib (AC0010) and its five metabolites in human cerebrospinal fluid: Application to a study of the blood-brain barrier penetration rate of non-small cell lung cancer patients.
Wang W; Zheng X; Wang H; Wang L; Jiang J; Hu P
J Pharm Biomed Anal; 2017 May; 139():205-214. PubMed ID: 28285073
[TBL] [Abstract][Full Text] [Related]
3. An UPLC-MS/MS method to determine CT-707 and its two metabolites in plasma of ALK-positive advanced non-small cell lung cancer patients.
Cui C; Hu P; Jiang J; Kong F; Luo H; Zhao Q
J Pharm Biomed Anal; 2018 May; 153():1-8. PubMed ID: 29455091
[TBL] [Abstract][Full Text] [Related]
4. Development of an LC-MS/MS method for quantifying ASK120067, a novel mutant-selective inhibitor of the epidermal growth factor receptor (EGFR) as well as its main metabolite in human plasma and its application in a pharmacokinetic study.
Cui X; Wang S; Gao H; Li B; Shi Y; Guo H; Song T; Zheng X
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1162():122488. PubMed ID: 33360679
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a UPLC-MS/MS method for quantification of osimertinib (AZD9291) and its metabolite AZ5104 in human plasma.
Zheng X; Wang W; Zhang Y; Ma Y; Zhao H; Hu P; Jiang J
Biomed Chromatogr; 2018 Dec; 32(12):e4365. PubMed ID: 30119142
[TBL] [Abstract][Full Text] [Related]
6. Validation of an LC-MS/MS method for simultaneous determination of icotinib and its four major circulating metabolites in human plasma and its application in a pharmacokinetic study.
Xiao Y; Maiolino P; Yan JH; Ma J; Li J; Chen L
Biomed Chromatogr; 2018 Nov; 32(11):e4327. PubMed ID: 29975793
[TBL] [Abstract][Full Text] [Related]
7. Development of an LC-MS/MS method for quantifying two main metabolites of abivertinib in human plasma.
Zheng X; Wang W; Zhang Y; Ma Y; Zhao H; Gao H; Hu P; Jiang J
Biomed Chromatogr; 2020 Feb; 34(2):e4704. PubMed ID: 31629371
[TBL] [Abstract][Full Text] [Related]
8. Determination of tulobuterol in rat plasma using a liquid chromatography-tandem mass spectrometry method and its application to a pharmacokinetic study of tulobuterol patch.
Han X; Liu R; Ji L; Hui M; Li Q; Fang L; Bi K
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1008():108-114. PubMed ID: 26638035
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of Guanfu base G and its active metabolites by UPLC-MS/MS in rat plasma and its application to a pharmacokinetic study.
Zhang L; Wang A; Wang X; Zhang Y; Li X; Liu P
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Apr; 957():1-6. PubMed ID: 24636893
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of ZL-01, a novel nucleotide prodrug, and its metabolites in rat plasma by LC-MS/MS: Application to pharmacokinetic study.
Chang R; Xu ST; Jin HW; Zhao YJ; Hu TY; Wang G; Wang J; Zhen L
J Pharm Biomed Anal; 2022 Jan; 208():114437. PubMed ID: 34735992
[TBL] [Abstract][Full Text] [Related]
11. Validation and Application of an LC-MS-MS Method for the Determination of Ceftizoxime in Human Serum and Urine.
Wang L; Zheng X; Zhong W; Chen J; Jiang J; Hu P
J Chromatogr Sci; 2016; 54(5):713-9. PubMed ID: 26896348
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous determination of selected tyrosine kinase inhibitors with corticosteroids and antiemetics in rat plasma by solid phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic interaction studies.
Maher HM; Alzoman NZ; Shehata SM
J Pharm Biomed Anal; 2016 May; 124():216-227. PubMed ID: 26966895
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of evodiamine and its four metabolites in rat plasma by LC-MS/MS and its application to a pharmacokinetic study.
Wang C; Yue F; Ai G; Yang J
Biomed Chromatogr; 2018 Jul; 32(7):e4219. PubMed ID: 29470848
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of parecoxib and its main metabolites valdecoxib and hydroxylated valdecoxib in mouse plasma with a sensitive LC-MS/MS method to elucidate the decreased drug metabolism of tumor bearing mice.
Jin X; Zhou F; Liu Y; Cheng C; Yao L; Jia Y; Wang G; Zhang J
J Pharm Biomed Anal; 2018 Sep; 158():1-7. PubMed ID: 29843006
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of puerarin, daidzin, daidzein, paeoniflorin, albiflorin, liquiritin and liquiritigenin in rat plasma and its application to a pharmacokinetic study of Ge-Gen Decoction by a liquid chromatography-electrospray ionization-tandem mass spectrometry.
Yan Y; Chai CZ; Wang DW; Wu J; Xiao HH; Huo LX; Zhu DN; Yu BY
J Pharm Biomed Anal; 2014 Jul; 95():76-84. PubMed ID: 24637051
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of imperatorin and its metabolite xanthotoxol in rat plasma and urine by LC-MS/MS and its application to pharmacokinetic studies.
Ngo L; Tran P; Ham SH; Cho JH; Cho HY; Lee YB
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():30-38. PubMed ID: 28064067
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a sensitive LC-MS/MS assay for the simultaneous quantification of allitinib and its two metabolites in human plasma.
Lin L; Gao Z; Chen X; Zhong D
J Pharm Biomed Anal; 2013 Dec; 86():49-55. PubMed ID: 23973791
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of FLZ and its metabolite (M1) in human plasma and urine by UHPLC-MS/MS: Application to a pharmacokinetic study.
Cui C; Chen R; Jiang J; Liu R; Wang W; Zhao Q; Hu P
J Pharm Biomed Anal; 2019 Feb; 164():32-40. PubMed ID: 30342394
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of erlotinib and tamoxifen in rat plasma using UPLC-MS/MS: Application to pharmacokinetic interaction studies.
Maher HM; Alzoman NZ; Shehata SM
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1028():100-110. PubMed ID: 27336702
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of bivalirudin, a novel anticoagulant peptide, in human plasma by LC-MS/MS: Method development, validation and application to pharmacokinetics.
Li XJ; Sun YT; Yin L; Zhang XJ; Yang Y; Paul Fawcett J; Cui YM; Gu JK
J Pharm Anal; 2013 Feb; 3(1):1-8. PubMed ID: 29403790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
